{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:10:52Z","timestamp":1774548652229,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.10.068","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T16:44:33Z","timestamp":1320770673000},"page":"29-34","source":"Crossref","is-referenced-by-count":50,"title":["Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source"],"prefix":"10.1016","volume":"30","author":[{"given":"C.J.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"DeTora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Anemona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (Suppl. 2)","key":"10.1016\/j.vaccine.2011.10.068_bib0005","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.10.068_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.17.5.553","article-title":"The results of the serum treatment in thirteen hundred cases of epidemic meningitis","volume":"17","author":"Flexner","year":"1913","journal-title":"J Exp Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.10.068_bib0015","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.10.068_bib0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/IAI.01044-09","article-title":"Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies","volume":"78","author":"Hellerud","year":"2010","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.10.068_bib0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.10.068_bib0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.10.068_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/INF.0b013e31818a0237","article-title":"A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents","volume":"28","author":"Jackson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.10.068_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.10.068_bib0045","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.10.068_bib0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.10.068_bib0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00068-09","article-title":"Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A\/C polysaccharide vaccine in adults","volume":"16","author":"Findlow","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.10.068_bib0060","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.10.068_bib0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"issue":"July (8447)","key":"10.1016\/j.vaccine.2011.10.068_bib0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"2","author":"Reingold","year":"1985","journal-title":"Lancet"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.10.068_bib0075","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.10.068_bib0080","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","article-title":"Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.10.068_bib0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/CVI.00036-08","article-title":"Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B","volume":"15","author":"Plested","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"June (Suppl. 2)","key":"10.1016\/j.vaccine.2011.10.068_bib0090","doi-asserted-by":"crossref","first-page":"B117","DOI":"10.1016\/j.vaccine.2009.04.066","article-title":"Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease","volume":"27","author":"Granoff","year":"2009","journal-title":"Vaccine"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.10.068_bib0095","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"March (9158)","key":"10.1016\/j.vaccine.2011.10.068_bib0100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(98)08350-0","article-title":"Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group","volume":"353","author":"Hibberd","year":"1999","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.10.068_bib0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1189\/jlb.0604342","article-title":"Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages","volume":"77","author":"Jack","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.10.068_bib0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"issue":"December (Suppl. 8)","key":"10.1016\/j.vaccine.2011.10.068_bib0115","doi-asserted-by":"crossref","first-page":"I40","DOI":"10.1016\/j.vaccine.2008.11.060","article-title":"Neisserial pathogenesis","volume":"26","author":"Welsch","year":"2008","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.10.068_bib0120","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/IAI.01561-08","article-title":"Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin","volume":"77","author":"Shaughnessy","year":"2009","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.10.068_bib0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.10.068_bib0130","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI114548","article-title":"A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass","volume":"85","author":"Lucas","year":"1990","journal-title":"J Clin Invest"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.10.068_bib0135","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.154.8.4195","article-title":"Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates","volume":"154","author":"Lucas","year":"1995","journal-title":"J Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.10.068_bib0140","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.4049\/jimmunol.150.5.2056","article-title":"Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide","volume":"150","author":"Lucas","year":"1993","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.10.068_bib0145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/168.3.663","article-title":"Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines","volume":"168","author":"Granoff","year":"1993","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T00:29:52Z","timestamp":1686443392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0264410X11017051"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}